Oncology Industry
Insights & Trends
March 23, 2023
Print Report CURRENT LANDSCAPE OF CELL THERAPY CLINICAL TRIALS The first cell therapy (Provenge) to treat cancer got FDA approval in 2010. Following the approval of […]
February 9, 2023
COVID-19 pandemic that emerged in 2019 has adversely affected human life globally. In addition to the health and socio-economic aspects, we have observed its effect on […]
May 24, 2021
COVID Vaccines, what’s new: an update on the latest clinical trials that are underway with the currently administered vaccines The global pandemic posed a challenge for […]
February 23, 2021
This week we saw two major deals in the ADC landscape of oncology: Gilead acquired Immunomedic’s Trop2-directed Trodelvy in a $21B deal, giving the company […]
September 12, 2020
We were deeply saddened to learn of Chadwick Boseman’s passing after a four year battle with colorectal cancer. Chadwick inspired and entertained millions through his portrayal […]
May 1, 2020
The National Institutes of Health released interim #data from the Phase 3 ACTT trial, which explores #remdesivir for the treatment of #Covid19. Interim findings show remdesivir […]
May 1, 2020
#Takeda has added a #Covid19 Expansion arm to their phase 1 trial exploring the small molecule TAK-981 in solid tumors and hematologic malignancies. As this #pandemic […]
April 30, 2020
#Kognitic has made it our mission to make #Covid19 clinical research publicly accessible. True accessibility not only requires data, but the knowledge necessary to interpret that […]
April 29, 2020
#Kognitic has made it our mission to make #Covid19 clinical research publicly accessible. True accessibility not only requires data, but the knowledge necessary to interpret that […]